Last reviewed · How we verify
Amnion collagen
At a glance
| Generic name | Amnion collagen |
|---|---|
| Sponsor | Egyptian Atomic Energy Authority |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Clinical Registry Collecting Real World Evidence on Wound Care Treatments
- Exploratory Clinical Research for the Evaluation of Human GMP (Good Manufacturing Practice) Collagen Implants (Humabiologics) in the Treatment of Corneal Melting (RCJ-COL3D-MC-01-2026) (NA)
- Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management (NA)
- Regenerative Outcomes for Peri-implant Bony Defects Using Amnion-chorion Barrier vs. Collagen Membrane (NA)
- Biotivity A-C Membrane Socket Preservation Study (PHASE4)
- Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa (PHASE1)
- Multicentric RCT Comparing High Purity Type I Collagen-Skin Substitute vs dHACM in Treatment of Diabetic Foot Ulcers (NA)
- High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amnion collagen CI brief — competitive landscape report
- Amnion collagen updates RSS · CI watch RSS
- Egyptian Atomic Energy Authority portfolio CI